Target intelligence / Profile preview

Yeast mitochondrial respiratory chain complex III (Complex III)

Target
Complex III
Molecular classification
Enzyme, Electron transport chain complex, Mitochondrial inner membrane protein complex
01

Overview

Yeast mitochondrial respiratory chain complex III, commonly referred to as the cytochrome bc1 complex or ubiquinol-cytochrome c reductase, is a multi-subunit enzyme complex located in the inner mitochondrial membrane of Saccharomyces cerevisiae and related species. It catalyzes the transfer of electrons from ubiquinol (coenzyme Q) to cytochrome c, a process coupled to the translocation of protons from the mitochondrial matrix to the intermembrane space, thus contributing to the proton motive force required for ATP synthesis. Complex III typically functions as a homodimer and forms supramolecular assemblies (supercomplexes) with other respiratory complexes, particularly complex IV, further optimizing electron flow and energy conversion. Its proper assembly and function require several core and accessory subunits, as well as specific assembly factors.[1][2][3][7] Inhibitors targeting complex III are used experimentally to probe mitochondrial function and can lead to severe bioenergetic defects. Mutations or defects in complex III or its assembly factors result in compromised cellular respiration and growth phenotypes in yeast, and by extension, similar pathologies in human disease.[1][2][6]

Other names
Cytochrome bc1 complexUbiquinol-cytochrome c reductasebc1 complex
02

Mechanism of action

Inhibition of electron transfer from ubiquinol to cytochrome c, disrupting proton gradient formation and ATP synthesis

03

Biological functions

Electron transfer in mitochondrial respirationProton translocation across the mitochondrial inner membraneATP production via oxidative phosphorylationFormation of respiratory supercomplexes
04

Disease associations

Neurodegenerative disease (by analogy to human mitochondrial disorders)Other (defects in assembly or function affect mitochondrial respiration and energy metabolism; associated with reduced cell growth and viability in yeast[1][6])
05

Safety considerations

Essential for cell viability: inhibition or genetic defects lead to impaired energy production, cell growth defects, and increased sensitivity to metabolic stress
06

Interacting drugs

Antimycin A

2 more in the full profile.

07

Biomarkers

Reduced respiration rateLoss of mitochondrial membrane potentialDecreased levels of assembled complex III subunits[1]

Beyond the preview

Go deeper on Yeast mitochondrial respiratory chain complex III (Complex III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yeast mitochondrial respiratory chain complex III (Complex III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call